Phthalates and Their Impacts on Human Health.

Wang Y, Qian H. · 2021

Read Phthalates and Their Impacts on Human Health. by Wang Y, Qian H. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8157593.txt.

Introduction

Wang and Qian assess phthalates and their impacts on human health. Phthalates are widely used chemicals that can disrupt hormones. They turn up in many goods that touch plastics during making, packing, or shipping.

Though each dose clears fast, steady exposure can harm many organs. The review links phthalates to risks in pregnancy, child growth, and fertility. It sets out toxicity paths and risk assessment methods. Harms to children get their own section. The authors review current limits and urge wider curbs or safer substitutes. Feasible steps to cut exposure close the article.

Catalog record

CREATORWang Y, Qian H.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8157593

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Phthalates and Their Impacts on Human Health By Yufei Wang, Haifeng Qian, Andrea Tittarelli Published in: Healthcare DOI: 10.3390/healthcare9050603 ABSTRACT Abstract Phthalates are a series of widely used chemicals that demonstrate to be endocrine disruptors and are detrimental to human health. Phthalates can be found in most products that have contact with plastics during producing, packaging, or delivering. Despite the short half-lives in tissues, chronic exposure to phthalates will adversely influence the endocrine system and functioning of multiple organs, which has negative long-term impacts on the success of pregnancy, child growth and development, and reproductive systems in both young children and adolescents. Several countries have established restrictions and regulations on some types of phthalates; however, we think that more countries should establish constraints or substitute measures for phthalates to reduce health risks. This article aims to summarize the adverse impacts of phthalates on human health, analyze the toxicity mechanism, assess the risks, and finally provide feasible strategies to reduce exposure of the public to phthalates. Keywords: risk assessment, endocrine disruptors, plastics, health impact, child growth 1. INTRODUCTION Plastic has brought great benefits to society since it was invented in 1907, however, it also has many negative impacts on the environment and human health, which has become a global problem. People are constantly exposed to plastics via contaminated food, packaging leachate (e.g., water bottle and medical devices), atmospheric fallout and urban dust containing microplastics, personal care products (PCPs) (e.g., cosmetic packaging), and synthetic clothing [1,2]. Long-term plastic exposure would inevitably lead to the leaching of many harmful substances. The most concerns include phthalates, bisphenol A (BPA), and polychlorinated biphenyls (PCB). These substances have been identified as endocrine-disrupting chemicals (EDCs) which interfere with normal hormonal actions [3,4]. Phthalates are a series of chemical substances, which are mainly used as plasticizers added to polyvinyl chloride (PVC) plastics for softening effects. Phthalates can potentially disrupt the endocrine system [5]. Health concerns regarding the detrimental impacts of phthalates on the development and reproductive system have been raised in the recent decades [6]. Compared to adults, children are much more vulnerable and sensitive to phthalates exposure, especially during early growth [7]. This review aims to summarize the impacts of phthalates on human health, especially on children, the mechanism and risk assessment of phthalates, and provide feasible strategies to reduce exposure of the public to phthalates. 2. PHTHALATES APPLICATIONS AND EXPOSURE ROUTES Phthalates, such as diethylhexyl phthalate (DEHP), dibutyl phthalate (DBP), diethyl phthalate (DEP), di-isononyl phthalate (DiNP), and di-iso-decyl phthalate (DiDP), are mainly used in the plastic industries as plasticizers to produce polyvinyl chloride (PVC). The short-branched low molecular weight phthalates, such as dimethyl phthalate (DMP) and DEP, are also widely produced and used in many industries, such as PCPs (e.g., hair products), pharmaceuticals, and medical devices (e.g., medical tubing) (Table 1). The global consumption of DEHP was estimated at 3.07 million tons (Global demand for plasticizers continues to rise, 2017). The estimated global market of phthalates in 2020 is expected to reach 10 billion USD and would still be widely used in plasticizers [8]. [Table: Common phthalate compounds.] Plastic waste has received scrutiny by governmental and regulatory bodies. Global plastic use consumes more than 3 million tons of phthalates per year [9]. Due to their ubiquity in the environment, human exposure to phthalates leached from waste plastics is virtually unavoidable. For instance, in China, plastic usage tripled over eight years from 2003 and 2011, and reached over 50 million tons of raw plastics produced and estimated to keep increasing in the following years [9]. As a result, the relative higher exposure to phthalates was found in China due to the high usage of plastics. In the USA, more than 340 million pounds of phthalates are consumed every year and cause potential health and environmental risks [10]. Phthalates can be easily leaching into food, water, and other products applied directly to the human body. The detrimental health and environmental effects have been increasingly studied to assess the extent of the impacts on society. An important phthalate exposure route could be consisted of ingestion, inhalation, and dermal contact mainly via PCPs [9]. Some dairy products, fish, seafood, and oils are found to have a high level of phthalates. For the residents who live near phthalates manufacturing industries, phthalates are more likely to enter the body through absorption via the skin and the polluted air due to fugitive emission [10]. Phthalates are semi-volatile organic compounds (SVOCs). DEHP and DBP are the main compounds in both indoor and outdoor air phthalates [11]. Dermal absorption also occurs from the daily use of PCPs containing phthalates via plastic package. Infants are exposed to phthalates by drinking breast milk with their mothers exposed to DEHP and DiNP, and sucking on toys containing DEHP, DBP, and BBP [10]. Phthalates are also found to cross the placenta-blood barrier, which is the major exposure route of the fetus [12]. 3. BIO-METABOLISM OF PHTHALATES IN HUMAN BODY The bio-metabolism in the human body is very rapid since phthalates have short biological half-lives, about 12 h [13]. Figure 1 presents the metabolic patterns. The first step of metabolism is hydrolyzation after absorption into cells. The second step is conjugation to form the hydrophilic glucuronide conjugate, which is catalyzed by the enzyme uridine 5′-diphosphoglucuronyl transferase [14]. The type of phthalates determines its toxicological fate in the body. Short-branched phthalates are often hydrolyzed to monoester phthalates and then excreted in the urine, while long-branched phthalates mainly undergo several bio-transformations, such as hydroxylation and oxidation, and then excreted in urine and feces as phase 2 conjugated compounds [15]. For example, the DEHP, which has complex branched chains, may be hydrolyzed to mono(2-ethylhexyl) phthalate (MEHP), mono(2-ethyl-5-hydroxyhexyl) phthalate, mono(2-ethyl-5-oxohexyl) phthalate, mono(2-ethyl-5-carboxypentyl) phthalate (MECPP), mono(2-carboxymethylhexyl) phthalate (MCMHP) or other metabolites. The metabolites of DEHP above could also be found in serum. According to the animal experiments, exposure to MEHP causes reproductive dysfunction in female zebrafishes, which is possibly due to the alteration in endocrine activities (elevated cortisol levels) [16]. In addition, according to half-life and distribution pattern, previous studies indicated that MECPP in urine and MCMHP in serum could be used as suitable biomarkers [14]. Most of the phthalates and their metabolites can be found in urine and feces, but some phthalates compounds (e.g., DEHP) and their metabolites can also be excreted in sweat [17]. Wittassek and Angerer found that the oxidative metabolism of DEHP is age-related. Younger children at the age of 6–7 years excrete more oxidative DEHP metabolites compared to mono-(2-ethylhexyl) phthalate (MEHP), one of the metabolites, than adults aged between 19 and 90 years [18]. [Figure: The metabolic pathway for phthalates.] 4. PHTHALATES TOXICOLOGY AND RISK ASSESSMENT In rodent studies, it was found that phthalates have low acute toxicity with a median lethal dose (LD50) of 1–30 g/kg bodyweight, and its toxicity is mainly concentrated in the liver, kidney, thyroid gland tissue, and testis [6]. Evidence for adverse effects on reproduction and development in animals and humans is ample. According to the laboratory experiment on pregnant animals, exposure to DBP at 100 mg/kg bodyweight/day is toxic to fetal development [6]. The no-observed-adverse-effect level for DEHP to humans is 4.8 mg/kg bodyweight/day and the tolerate daily intake (TDI) is 48 μg/kg bodyweight

Read the complete text